Erythromycin 12 hydroxylase
Erythromycin 12 hydroxylase | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
EC number | 1.14.13.154 | ||||||||
Databases | |||||||||
IntEnz | IntEnz view | ||||||||
BRENDA | BRENDA entry | ||||||||
ExPASy | NiceZyme view | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
|
Erythromycin 12 hydroxylase (EC 1.14.13.154, EryK) is an enzyme with systematic name erythromycin-D,NADPH:oxygen oxidoreductase (12-hydroxylating) .[1][2][3] This enzyme catalyses the following chemical reaction
- erythromycin D + NADPH + H+ + O2 erythromycin C + NADP+ + H2O
Erythromycin 12 hydroxylase is responsible for the C-12 hydroxylation of the macrolactone ring.
References
- ↑ Lambalot, R.H.; Cane, D.E.; Aparicio, J.J.; Katz, L. (1995). "Overproduction and characterization of the erythromycin C-12 hydroxylase, EryK". Biochemistry. 34 (6): 1858–1866. doi:10.1021/bi00006a006. PMID 7849045.
- ↑ Savino, C.; Montemiglio, L.C.; Sciara, G.; Miele, A.E.; Kendrew, S.G.; Jemth, P.; Gianni, S.; Vallone, B. (2009). "Investigating the structural plasticity of a cytochrome P450: three-dimensional structures of P450 EryK and binding to its physiological substrate". J. Biol. Chem. 284 (42): 29170–29179. doi:10.1074/jbc.M109.003590. PMC 2781461. PMID 19625248.
- ↑ Montemiglio, L.C.; Gianni, S.; Vallone, B.; Savino, C. (2010). "Azole drugs trap cytochrome P450 EryK in alternative conformational states". Biochemistry. 49 (43): 9199–9206. doi:10.1021/bi101062v. PMID 20845962.
External links
- Erythromycin 12 hydroxylase at the US National Library of Medicine Medical Subject Headings (MeSH)
This article is issued from Wikipedia - version of the 5/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.